TriGemX Bio Undisclosed stage: $94M

Oct 1, 2026Public sources — Collected from public sources, not yet cross-checked.

TriGemX Bio raised $94 million in an undisclosed stage round led by The Column Group and TCG Crossover and Viking Global Investors, announced Oct. 1.

Facts

Company: TriGemX Bio
Amount: $94 million
Currency: USD
Stage: Undisclosed stage
Announced: Oct 1, 2026
Instrument: Equity

Investors

Led by: The Column Group TCG Crossover Viking Global Investors

Sources

1.The AlleyWatch Startup Daily Funding Report: 10/2/2026 — AlleyWatch, Oct 2, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Oct 15, 2026